Literature DB >> 10860639

The effect of rebamipide on cisplatin-induced nephrotoxicity in rats.

S Y Saad1, T A Najjar, M O Al-Sohaibani.   

Abstract

This study aimed to evaluate the protective effect of rebamipide (free radical scavenger) against the nephrotoxic effect induced by cisplatin in normal rats. Twenty-four male Wister albino rats were divided equally into four groups: control, rebamipide, cisplatin and cisplatin plus rebamipide-treated groups. Nephrotoxicity was induced with single intravenous (i.v.) cisplatin dose of 6 mg kg(-1)and measured through the estimation of kidney weight, serum albumin (Alb), serum creatinine (Cr), blood urea nitrogen (BUN), kidney glutathione (GSH) and malondialdehyde (MDA) production. In the cisplatin-treated group the kidney weight as a percent of the total body weight, serum Alb, serum Cr, BUN, GSH content and MDA amount were: 0.61+/-0.054%, 2.84+/-0.24 g dl(-1), 2.99+/-0.10 mg dl(-1), 147.08+/-7.46 mg dl(-1), 3.11+/-0.238 micromol g(-1)and 1449. 09+/-127.36 nmol g(-1), respectively. All the previous changes were significantly (P<0.01) different from the corresponding values in the control group. In addition, histopathological examination of the kidney tissue revealed degenerative cellular material and apoptotic tubular cells were seen in the renal tubules. Rebamipide treatment (140 mg kg(-1), i.p.) for 1 week ameliorated all the previous changes and the results recorded for the cisplatin plus rebamipide-treated group were: 0.45+/-0.035%, 4.17+/-0.091 g dl(-1), 1.37+/-0.209 mg dl(-1), 72.25+/-5.14 mg dl(-1), 5.063+/-0.269 micromol g(-1)and 560.23+/-21.98 nmol g(-1)for the previous tests, respectively. Furthermore, significant improvement in the kidney histopathology was observed. The results of this study clearly revealed that rebamipide protected the kidney against the nephrotoxic effect of cisplatin. These results suggest that lipid peroxidation is not the only mechanism by which cisplatin induced nephrotoxicity. More investigations are needed to confirm the effect of rebamipide and at the same time to elucidate the exact mechanism by which cisplatin induces nephrotoxicity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860639     DOI: 10.1006/phrs.2000.0662

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Rebamipide promotes healing of colonic ulceration through enhanced epithelial restitution.

Authors:  Tomohisa Takagi; Yuji Naito; Kazuhiko Uchiyama; Toshimitsu Okuda; Katsura Mizushima; Takahiro Suzuki; Osamu Handa; Takeshi Ishikawa; Nobuaki Yagi; Satoshi Kokura; Hiroshi Ichikawa; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

Review 2.  15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications.

Authors:  Tetsuo Arakawa; Kazuhide Higuchi; Yasuhiro Fujiwara; Toshio Watanabe; Kazunari Tominaga; Eiji Sasaki; Nobuhide Oshitani; Toshikazu Yoshikawa; Andrzej S Tarnawski
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  Resolution of persistent corneal erosion after administration of topical rebamipide.

Authors:  Tomoyuki Kashima; Hideo Akiyama; Fumihide Miura; Shoji Kishi
Journal:  Clin Ophthalmol       Date:  2012-08-29

Review 4.  Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal.

Authors:  Tomoyuki Kashima; Hirotaka Itakura; Hideo Akiyama; Shoji Kishi
Journal:  Clin Ophthalmol       Date:  2014-05-30

5.  Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.

Authors:  Sejeong Park; So Young Park; Yu Jin Kim; Soo Min Hong; Suk Chon; Seungjoon Oh; Jeong Taek Woo; Sung Woon Kim; Young Seol Kim; Sang Youl Rhee
Journal:  Diabetes Metab J       Date:  2016-04-21       Impact factor: 5.376

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.